Valuation: Bide Pharmatech Co., Ltd.

Capitalization 4.17B 573M 546M 512M 454M 816M 48.59B 902M 6.29B 2.33B 20.02B 2.15B 2.1B 88.04B P/E ratio 2024 *
35x
P/E ratio 2025 * 29.2x
Enterprise value 4.17B 573M 546M 512M 454M 816M 48.59B 902M 6.29B 2.33B 20.02B 2.15B 2.1B 88.04B EV / Sales 2024 *
3.55x
EV / Sales 2025 * 3.11x
Free-Float
-
Yield 2024 *
-
Yield 2025 * -
More valuation ratios * Estimated data
Dynamic Chart
1 day-4.14%
1 week+5.01%
Current month+2.30%
1 month-3.52%
3 months+57.88%
6 months+42.14%
Current year-14.97%
More quotes
1 week
45.34
Extreme 45.34
50.99
1 month
39.71
Extreme 39.71
50.99
Current year
28.50
Extreme 28.5
56.00
1 year
28.50
Extreme 28.5
60.37
3 years
28.50
Extreme 28.5
114.05
5 years
28.50
Extreme 28.5
114.05
10 years
28.50
Extreme 28.5
114.05
More quotes
Director TitleAgeSince
Chief Executive Officer - 2023-10-12
Chief Tech/Sci/R&D Officer 41 2008-03-31
Chief Tech/Sci/R&D Officer 41 2008-02-29
Manager TitleAgeSince
Chairman 44 2020-09-30
Director/Board Member 58 2023-10-12
Director/Board Member 44 2023-10-12
More insiders
Add to a list
Change 5d. change 1-year change 3-years change Capi. ($)
-4.14%+5.01%-19.54% - 598M
-2.81%+2.03%+63.44%-28.21%44.57B
-0.56%-1.33%-11.51%-25.88%36.37B
+4.60%+6.85%+5.45%-1.37%26.67B
-1.45%-4.10%-24.76%-24.86%17.4B
-1.90%-4.57%-46.04%-84.41%16.48B
-0.31%-2.42%+40.39%+88.65%16.14B
-2.35%+0.99%+1.68%-36.01%12.18B
-0.80%-1.04%+16.75%+68.18%10.77B
-1.20%+4.81%+2.47%-19.41%10.21B
Average -1.06%+2.46%+2.83%-7.04% 19.14B
Weighted average by Cap. -0.67%+3.14%+11.66%-13.26%
See all sector performances

Financials

2024 *2025 *
Net sales 1.17B 161M 154M 144M 128M 229M 13.67B 254M 1.77B 655M 5.63B 606M 592M 24.77B 1.34B 184M 175M 164M 146M 262M 15.6B 289M 2.02B 747M 6.43B 691M 676M 28.26B
Net income 123M 16.91M 16.11M 15.1M 13.39M 24.07M 1.43B 26.61M 186M 68.69M 591M 63.53M 62.11M 2.6B 147M 20.19M 19.24M 18.04M 16M 28.74M 1.71B 31.77M 222M 82.03M 706M 75.87M 74.17M 3.1B
Net Debt - -
More financial data * Estimated data
Logo Bide Pharmatech Co., Ltd.
Bide Pharmatech Co Ltd is a China-based company mainly engaged in pharmaceutical research and development. The Company's main businesses are the research, development, design, production and sales of drug molecular building blocks. The Company's main products are pharmaceutical molecular building blocks and scientific reagents. The Company's products are mainly used in drug target discovery, seed compound screening, lead compound discovery, synthesis and optimization. The Company conducts business in Asia Pacific, India, Europe, the United States and other regions.
Employees
846
More about the company
Date Price Change Volume
24-12-12 47.19 ¥ -4.14% 1,356,833
24-12-12 49.23 ¥ +2.97% 2,169,054
24-12-11 47.81 ¥ +4.71% 1,101,428
24-12-10 45.66 ¥ -2.83% 1,567,362
24-12-09 46.99 ¥ +0.23% 2,027,149

End-of-day quote Shanghai S.E., December 12, 2024

More quotes
Trading Rating
Investor Rating
ESG Refinitiv
surperformance-ratings-light-chart BIDE-PHARMATECH-CO-LTDMore Ratings
Sell
Consensus
Buy
Mean consensus
BUY
Number of Analysts
2
Last Close Price
47.19CNY
Average target price
50.00CNY
Spread / Average Target
+5.95%
Consensus

Annual profits - Rate of surprise

  1. Stock Market
  2. Equities
  3. 688073 Stock